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In the last years, different nanotools have been developed to fight cancer cells. They
could be administered alone, exploiting their intrinsic toxicity, or remotely activated to
achieve cell death. In the latter case, ultrasound (US) has been recently proposed
to stimulate some nanomaterials because of the US outstanding property of deep
tissue penetration and the possibility of focusing. In this study, for the first time,
we report on the highly efficient killing capability of amino-propyl functionalized ZnO
nanocrystals (ZnO NCs) in synergy with high-energy ultrasound shock waves (SW) for
the treatment of cancer cells. The cytotoxicity and internalization of ZnO NCs were
evaluated in cervical adenocarcinoma KB cells, as well as the safety of the SW treatment
alone. Then, the remarkably high cytotoxic combination of ZnO NCs and SW was
demonstrated, comparing the effect of multiple (3 times/day) SW treatments toward
a single one, highlighting that multiple treatments are necessary to achieve efficient
cell death. At last, preliminary tests to understand the mechanism of the observed
synergistic effect were carried out, correlating the nanomaterial surface chemistry to the
specific type of stimulus used. The obtained results can thus pave the way for a novel
nanomedicine treatment, based on the synergistic effect of nanocrystals combined with
highly intense mechanical pressure waves, offering high efficiency, deep and focused
tissue penetration, and a reduction of side effects on healthy cells.
Keywords: zinc oxide, shock waves, anticancer therapy, acoustic cavitation, reactive oxygen species, ultrasound
non-thermal effects
INTRODUCTION
Among various innovative new approaches to fight cancer, nanomedicine has attracted many
interests (Shi et al., 2017). The application of nanomaterials for health and medicine can lead
successful advancements in diagnosis and therapy (Zavaleta et al., 2017), particularly in the delivery
of cargo molecules (Tran et al., 2017), or through their direct use to damage cancer cells (Chugh
et al., 2018). Such nanotools indeed could be intrinsically toxic (Bisht and Rayamajhi, 2016),
e.g., through the release of metal ions, or could be remotely activated to achieve cell death,
as in the photothermal and photodynamic therapies (Lim et al., 2015). Zinc Oxide (ZnO) in
particular has raised researchers’ interest thanks to its biocompatibility and peculiar piezoelectric
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and semiconductive properties (Jiang et al., 2018; Racca et al.,
2018) useful for its exploitation for imaging (Jiang et al., 2011),
biosensing (Sanginario et al., 2016; Shanmugam et al., 2017;
Stassi et al., 2017), tissue engineering (Laurenti and Cauda,
2017) and drug delivery (Laurenti and Cauda, 2018; Martínez-
Carmona et al., 2018) purposes. Remarkably, ZnO nanoparticles
are also studied for their intrinsic anticancer properties thanks to
their selective toxicity toward cancer cells (Bisht and Rayamajhi,
2016). ZnO cytotoxicity indeed is related to reactive oxygen
species (ROS) production and Zn2+ ions release (Bisht and
Rayamajhi, 2016; Jiang et al., 2018; Racca et al., 2018; Singh,
2019). Additionally, their toxic effects could be controlled and
amplified through an external stimulation by their irradiation
with ultraviolet light, as in the photodynamic therapy (PDT)
(Ancona et al., 2018), producing ROS and exerting then a
cytotoxic effect on cancer cells (Ancona et al., 2018; Kwiatkowski
et al., 2018). However, the limited tissue penetration depth of UV
light (less than 1 mm) reduces the ZnO-assisted PDT application
to superficial cancers, i.e., melanomas. Otherwise, the light source
has to be directly placed in the target tissue, as in the optic-fiber
guided PDT (Mallidi et al., 2016; Baskaran et al., 2018).
An alternative therapeutic approach, namely the sonodynamic
therapy (SDT), was also proposed (Shibaguchi et al., 2011). It is
based on the activation through ultrasound (US) of an organic
molecule, called sonosensitizer, to induce cells to death. US is
a mechanical pressure wave with the outstanding properties of
deep tissue penetration and focusing (Shibaguchi et al., 2011;
Wan et al., 2016). The passage of an US wave through a tissue
can exert two different consequences: thermal and non-thermal
effects. Even though US thermal effects can be exploited to
achieve tumor thermoablation, as in the high intensity focused
US (HIFU) therapy, SDT investigations are generally based on
the non-thermal ones (Canavese et al., 2018). Non-thermal effects
consist in a vast group of phenomena. Among them, acoustic
cavitation is probably the most studied (Canavese et al., 2018).
The term “cavitation” refers to the formation and the oscillations
of gas microbubbles in the medium under US stimulation.
Indeed, US passage provokes compression and rarefaction cycles,
in which gas bodies, already present in tissues, can form
microbubbles that expand and shrink following wave cycles.
Microbubbles can oscillate on their radius for several cycles,
inducing a potential temperature increase, microstreamings,
radiation forces and shear stress, in a situation of stable or
non-inertial cavitation. Otherwise, microbubbles can collapse
generating very high localized pressures and temperatures
(Rosenthal et al., 2004), capable to induce the formation of several
ROS and thus induce oxidative stress (Canavese et al., 2018).
Microbubble collapse causes also mechanical stress, with the
formation of microjets and shock waves (SW), and the emission
of light. This state is described as inertial or transient cavitation
(Canavese et al., 2018).
It is generally recognized that nanoparticles amplify US toxic
effects (Canavese et al., 2018). It was experimentally observed
indeed that nanoparticles addition decreases the US dose
necessary to obtain acoustic cavitation, because nanoparticles
carry gas pockets on their structure thanks to their surface
roughness and/or porosity. This fact results in an improvement
of the number of active microbubbles under the US irradiation
(Sviridov et al., 2015).
Some groups proposed to employ high-energy SW to activate
the organic molecular sonosentizer minimizing the US-related
thermal effects, enhancing instead non-thermal ones (Wan et al.,
2016). SW indeed are sonic pulses characterized by a first very
rapid positive pressure phase (up to 100 MPa) that lasts for 0.5–
3 µs, followed by a tensile wave characterized by a negative
pressure (−10 MPa) for 2–20 µs, then recovering ambient
values (Ogden et al., 2001; Wan et al., 2016). SW has been
evaluated to enhance the intracellular drug delivery (Canaparo
et al., 2008; Zhang et al., 2019) and for the activation of various
porphyrin complexes (Canaparo et al., 2006, 2013; Serpe et al.,
2011; Foglietta et al., 2015; Varchi et al., 2015). However, to our
knowledge there are no investigations exploiting the non-thermal
effect of SW assisted by solid nanoparticles. The combined use
of SW with solid nanoparticles can induce the great above-
mentioned advantages, i.e., improve the SW efficacy. This is
achieved thanks to the enhanced cavitation effects produced by
the presence of solid nanoparticles. Furthermore, the use of ZnO
nanoparticles and SW to induce cancer cell death has not already
been reported in the literature.
Herein, for the first time, we demonstrate the highly
efficient killing capability of amino-propyl functionalized ZnO
nanocrystals (ZnO NCs) in combination with SW for the
treatment of cancer in an in vitro study. ZnO NCs were
synthetized through a microwave-assisted solvothermal approach
and chemically characterized. This synthetic strategy provides a
high yield of ZnO NCs with spherical shape and very uniform
nanosized distribution, allowing for their high colloidal stability.
Our previous investigation indeed demonstrated the achievement
of reproducible and reliable biological results with such ZnO
NCs (Garino et al., 2019a). The cytotoxicity and internalization
of ZnO NCs were evaluated in cervical adenocarcinoma KB
cells, as well as the safety of the SW treatment alone. Then, the
remarkably high cytotoxic combination of ZnO NCs and SW
was demonstrated, comparing the effect of multiple (3 times/day)
SW treatments to a single one. At last, preliminary tests to
undertake the mechanism of the observed synergistic effect were
carried out. The obtained results highlight the effective anticancer
applicability of the proposed nanomedicine treatment, based on
the synergistic effect of ZnO NCs and highly intense and focalized
mechanical pressure waves.
MATERIALS AND METHODS
ZnO NCs Synthesis and
Functionalization
ZnO NCs were synthesized by a microwave-assisted
hydrothermal route, as previously described (Garino et al.,
2019a). ZnO NCs surface was then decorated with amino-propyl
functional groups and coupled with fluorescent Atto633-NHS
ester dye (Thermofischer) when necessary. ZnO NCs were stored
as ethanol colloidal suspensions.
ZnO NCs were characterized by X-Ray Diffraction (XRD)
with a Cu-Kα source of radiation, operating at 40 kV and
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30 mA in configuration θ–2θ Bragg-Brentano (Panalytical X’Pert
diffractometer). For this analysis, several drops of the colloidal
ZnO NCs solution were deposited on a silicon wafer and allowed
to dry at room temperature (RT). The XRD spectrum was
collected in the range of 20◦–65◦ with a step size of 0.02◦ (2θ)
and an acquisition time of 100 s.
High-resolution transmission electron microscopy (HRTEM)
was used to characterize the morphological and structural
features of the different materials. HRTEM was performed by
using a FEI Titan ST microscope working at an acceleration
voltage of 300 kV, equipped with a S-Twin objective lens, an
ultra-bright field emission electron source (X-FEG) and a Gatan
2k × 2k CCD camera. All the ZnO NCs samples were diluted in
ultrapure ethanol (99%) down to a concentration of 100 µg/mL.
One drop of each sample was deposited on a holey carbon
copper grid with 300-carbon mesh and left to dry overnight,
prior to imaging.
Dynamic Light Scattering (DLS) and Z-Potential
measurements were carried out with Zetasizer Nano ZS90
(Malvern Instruments). The size of pristine and amino-propyl
functionalized ZnO NC was measured in both ethanol and
double distilled (dd) water at a concentration of 100 µg/mL.
Z-Potential measurements were performed in dd water at a
concentration of 100 µ g/mL.
Cell Line
Cervical adenocarcinoma KB cell line (ATCC R© CCL17TM)
was grown in Eagle’s Minimum Essential Medium (EMEM,
Sigma) supplemented with 10% heath inactivated fetal
bovine serum (FBS, Sigma), 100 units/mL penicillin and
100 µg/mL streptomycin (Sigma) and maintained at 37◦C, 5%
CO2 atmosphere.
Cytotoxicity Tests
A 1.5 × 103 cells/well were plated in replicates (n = 4) into
96-well culture plates (TC-Treated, Corning) and incubated at
37◦C, 5% CO2. 24 h later, the culture medium was replaced
with fresh medium containing different concentrations of ZnO
NCs (5, 10, 15, 20, 25, 50 µg/mL). The ZnO NCs stock
solution (1 mg/mL) was sonicated in a water bath (Labsonic
LBS 2–10, Falc Instrument) at 40 kHz for 10 min before
the preparation of the aliquots. After the incubation time,
cell proliferation was assessed by the WST-1 cell proliferation
assay. 10 µL of the WST-1 reagent (Roche) were added to
each well and after 2 h incubation, the formazan absorbance
was measured at 450 nm by the Multiskan GO microplate
spectrophotometer (Thermo Fisher Scientific) using 620 nm
as reference wavelength. Control values, represented by cells
incubated with medium alone, were set at 100% viable and
all values were expressed as a percentage of the control. Cell
viability was measured after 5, 24, 48, and 72 h of incubation with
ZnO NCs.
Internalization Assay
ZnO NCs uptake in KB cells was measured with a Guava Easycyte
6-2L flow cytometer (Merck Millipore). Briefly, cells were seeded
into a 6-well TC treated culture plate (Corning) with cell culture
medium 24 h before the assay (1 × 105 cells/well). Then,
culture medium was replaced with freshly prepared medium
containing ZnO NCs labeled with Atto633-NHS (10 µg/mL).
A control well, containing untreated cells, was on the contrary
filled with fresh medium without NCs. ZnO NCs progressive
uptake was then measured at different time points (5–24 h).
Cells were washed twice with phosphate saline buffer (PBS),
trypsinized and centrifuged at 130 g for 5 min. Cell pellets
were then re-suspended in 1 mL PBS and immediately analyzed
with the flow cytometer. 1 × 104 gated events were considered
excluding cellular debris, characterized by low forward scatter
(FSC) and side scatter (SSC), with a flow rate of 0.59µL/s. Results
are shown as the percentage of positive events, analyzed with
Incyte Software (Merck Millipore). In particular, a threshold of
positivity upon control cell histogram was set. The percentage
of events characterized by a shift in Red-R fluorescence
intensity (emission filter 661/15 nm), due to the Atto633
attached on NCs surface, was thus measured. Representative
histograms were then graphed with FCS Express Software
(DeNovo Software).
Single SW Treatment
KB cells, seeded into a treated culture flask, in exponential growth
phase, where trypsinized and 5 × 105 cells per well were plated
in culture medium into a 96-well plate (Corning) for the SW
treatment as described by others (Canaparo et al., 2008, 2013;
Foglietta et al., 2017).
SW was administered by the high-energy focalized SW device
PW2 (R. Wolf, ELvation Medical). According with the previously
mentioned literature, energy flux density ranges, corresponding
to the energy at the focal point, were set, i.e., 0.15-0.22-0.3-0.4-
0.52 mJ/mm2, corresponding to positive peak pressures (PPP) of
29.1, 39.4, 50.3, 61.7, and 74.1 MPa. Furthermore, 500 or 1000
shots were given for each treatment (4 shots/s). The therapy
source FB10G4, equipped with a 4 cm thick pad, was employed
to give the SW treatment. The 96-well plate containing KB cells
was directly put on the top of the cap covered by a thin layer of
ultrasound gel (Stosswellen Gel 144 Bestelle, ELvation Medical)
to minimize SW attenuation. Immediately after the treatment,
2 × 103 cells were seeded in 100 µL of culture medium in
replicates (n = 4) in a 96-well culture plate for the WST-1
proliferation assay. Control wells containing the untreated cells,
plated in the same conditions of the SW-treated samples, were
also prepared. As before, the values kept from the untreated cells
were set at 100% viability.
The experiments were then repeated, following the same
protocol, preparing two flasks of KB and pre-incubating one with
a freshly prepared solution of ZnO NCs (10 µg/mL per 24 h
incubation) for the evaluation of the ZnO NCs-SW synergy. In
this case, an additional control with KB cells, incubated with ZnO
NCs but not irradiated with SW, was prepared.
Multiple SW Treatments
Since adherent cells bear multiple detachments, the protocol
employed for the single treatment carried out from the literature
was modified similarly to what reported by Marino et al. (2018,
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2019) for the multiple treatments. Briefly, 1.5 × 103 cells were
seeded into 100 µL of culture medium in a 96-well culture plate
in replicates (n = 4). 24 h later, two wells were incubated with
ZnO NCs (10 µg/mL) while the other two were re-filled with
fresh medium. After 24 h, all the wells were washed with PBS
and re-filled with 100 µL fresh culture medium. SW treatments
were then performed (3 times/day, one every 4 h). 24 h after
the last treatment, cell viability was carried out with the WST-1
proliferation assay.
ROS Scavenging Assay
The observed cell death upon the sonosensitizer activation is
frequently related in the literature with the ROS production
(Canavese et al., 2018; Vighetto et al., 2019). For this reason,
the experiments with ZnO NCs and multiple SW treatments
were repeated by pre-incubating KB cells with two different
antioxidants in order to evaluate ROS involvement in cell
proliferation upon ZnO NCs incubation and SW treatment.
N-acetylcysteine (NAC, Sigma) and mannitol (MAN, Sigma)
were chosen as ROS scavengers for this purpose.
It is reported that NAC could enhance cell antioxidant
properties through increasing intracellular GSH and interacting
with radicals such as H2O2 and OH• (Aruoma et al., 1989). MAN
is instead an OH• scavenger (Goldstein and Czapski, 1984).
For NAC the successfully employed protocol by Brazzale
et al. (2016) was followed. Briefly, 1 h before the first SW
treatment, but already after the 24 h incubation with ZnO
NCs, cell medium was replaced with a solution composed by
culture medium with the addition of 5 mM NAC. This solution
was discarded before the first SW treatment and cells were
resuspended in culture medium (100 µL). Cell viability was
measured with the WST-1 assay 24 h after the last treatment, as
described before. In order to exclude potential toxic effects of the
antioxidant alone, a well with untreated cells without NAC was
also prepared.
For MAN the concentration was 0.1 M for 30 min incubation
before the SW application (Yumita et al., 2010).
Kinetic Evaluation of Cell Death
The kinetic evaluation of cell apoptosis and necrosis was
performed with the RealTime-Glo Annexin V Apoptosis and
Necrosis Assay (Promega). Plate signals were collected with the
microplate reader Glomax (Promega).
KB cells were plated in a black 96-well plate with clear bottom
(Corning) following the same protocol already mentioned
for the SW multiple treatments. Control wells were also
prepared with culture medium to define the background of the
luminescence and the fluorescence derived from the medium
without cells. These values were subtracted from the test samples
as recommended by the manufacturers.
The background of the samples was measured, then 100 µL
of the reaction mix containing all the substrates for the reaction
were added and immediately a second reading was performed.
Then the signals were measured after each SW treatment and
24 h after the last one to have a comparison with the WST-1
viability tests.
Statistical Analysis
Measurement data were presented as mean ± standard error
mean (SEM). Each assay was done at least in duplicate. One-
way and two-way analysis of variance (ANOVA) were performed
with the Sigmaplot software. ***p < 0.001, **p < 0.01, and
*p < 0.05 were considered significant. A detailed report of the
statistical analysis performed on each experiment is reported in
the Supplementary Material.
RESULTS AND DISCUSSION
ZnO NCs, prior to the functionalization, were analyzed with
XRD, shown in Figure 1A, and compared with the standard
XRD pattern of ZnO (JCPDS card n. 36–1451) confirming that
the pristine ZnO NCs showed the typical hexagonal wurtzite
crystalline structure, with diffraction peaks corresponding to the
Miller’s index indicated in Figure 1A.
The HRTEM results (Figures 1B,C) additionally displayed
that both the pristine and amino-functionalized NCs had a
spherical morphology with size ranging from 15 to 25 nm and
a single crystalline nature, in particular a wurtzite hexagonal
structure, as already observed in our previous publication
(Garino et al., 2019a).
The grafting of the amino-functional groups imparted to ZnO
NCs a strong positive Z-potential in dd water (+22 mV), higher
than the Z-potential recorded for pristine ZnO NCs (+15 mV),
as shown in Figure 1D. DLS analyses were performed in both
ethanol and dd water showing that amino-functionalized ZnO
NCs hydrodynamic size was 79 nm in ethanol and 164 nm in
dd water (Figure 1F), thus smaller than the hydrodynamic size
of pristine ZnO NCs (91 nm in ethanol and aggregated in dd
water, with 531 nm in size, Figure 1E). The positive charge of
amino-functionalized ZnO NCs thus improves their colloidal
stability in solution and can also possibly increase their uptake in
cells, characterized mainly by negatively charged cell membranes
(Albanese et al., 2012). Additionally, the amino functionalization
allows the conjugation with different fluorescent dyes (Yu et al.,
2014) for their further characterization at flow cytometry to test
the internalization rate in cancer cells.
The viability of KB cancer cells after the incubation with
different concentrations of ZnO NCs (5, 10, 15, 20, 25, 50µg/mL)
was assessed at different time points, as depicted in Figure 2, i.e.,
after 5, 24, 48, and 72 h. A dose dependent response was indeed
observed, with a progressive decrease of cell viability increasing
the concentration of ZnO NCs and confirming the previous
results obtained at 24 h employing the same NCs (Garino et al.,
2019a). ZnO NCs at the concentrations of 5 and 10 µg/mL
resulted to be non-toxic for KB cells, while the mean percentages
of cell viability progressively decreased starting from 15 µg/mL
at all the considered time points. Moreover, the differences in
cell viability between the safest conditions, i.e., 5–10 µg/mL,
and the other ones continued to increase starting from 5 h of
incubation. While a mild proliferative effect was observed at the
lowest dosages at 48 h, cells incubated with 20-25-50 µg/mL of
ZnO NCs never recovered and their viability drastically dropped
after 24, 48, and 72 h. Interestingly, after 72 h a recovery of cells
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FIGURE 1 | ZnO NCs characterization. (A) XRD analysis. (B) HRTEM of pristine ZnO NCs and (C) amino-functionalized ZnO NCs, scale bar = 10 nm. The inset in C
represents a higher magnification image of amino-functionalized ZnO NCs. (D) Z-potential of pristine and amino-functionalized ZnO NCs. DLS measurements of (E)
pristine and (F) amino-functionalized ZnO NCs both in ethanol (black curve) and dd water (red curve).
FIGURE 2 | ZnO NCs cytotoxicity on KB cells at different time points detected
with the WST-1 assay. KB cells were incubated with different ZnO NCs
concentrations (5, 10, 15, 20, 25, and 50 µg/mL). Cell viability was measured
after 5, 24, 48, and 72 h. Bars represent mean ± SEM percentages of cell
viability with respect to the control cells, n = 3.
incubated with 15 µg/mL was evidenced, with percentages of cell
viability increasing from 57± 17% at 48 h up to 73± 9% at 72 h.
The complete statistical analysis of these data is reported in the
Supplementary Material.
ZnO NCs toxicity could be ascribed to two main events: the
Zn2+ ions release and ROS production, as previously mentioned
(Racca et al., 2018). The increase of NCs concentration
exasperated both the reported effects, resulting in a marked
decrease of cell growth.
The observed proliferative effect was also yet reported. Indeed,
Zn2+ ions are involved in many cellular pathways, and thus a
low dosage might enhance cell proliferation inducing key signal
proliferation pathways (Liu et al., 2017).
Dedicated analyses of NC internalization were performed with
the flow cytometry, detecting the Atto633 dye labeled ZnO NCs
fluorescence inside the cells at progressive time points (5 and
24 h). In particular, the internalization of ZnO NCs-Atto633 at
the concentration of 10 µg/mL was monitored, as it was the
highest safe concentration in the previous cytotoxicity analysis.
As it is possible to observe in Figure 3, a progressive increase
of cells presenting a shift of the Red-R intensity, due to the NCs
internalization, was recorded. A marked shift of the green curve,
representing cells incubated with ZnO NCs-Atto633 for 5 h was
also observed with respect to the black curve, corresponding to
the untreated cells signal, suggesting that NCs internalization
occurred quite rapidly. After 24 h of incubation, the percentage
of cells internalizing the NCs increased, as noticeable from the
orange curve, representing the signal of cells incubated with
ZnO NCs-Atto633 at 10 µg/mL for 24 h. In particular, the
percentage of positive events increased from 85 ± 3% at 5 h to
98.0± 0.4% at 24 h.
These results suggest that ZnO NCs were rapidly internalized
in KB cells and, upon a longer incubation time, i.e., 24 h, almost
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FIGURE 3 | Representative curves of ZnO NCs uptake in KB cells at different
dosages and at different time point (5–24 h) of incubation. Black curve
represents untreated cells signal (Ctrl), green curve regards signal generated
by cells incubated with ZnO NCs 10 µg/mL for 5 h and orange one by the
cells incubated with ZnO NCs 10 µg/mL for 24 h.
all cells have internalized the highest amount of NCs. This result
is indicated by the higher fluorescence intensity of these cells, as it
is possible to observe in the pronounced shift of the orange curve
with respect to the green one.
After the ZnO NCs characterization and the first tests to
assess their cytotoxicity and internalization, the non-lethal dose
of 10 µg/mL was identified as a safe condition for further
investigations in combination with SW. In addition, 24 h seems
to be a suitable incubation time, because almost all the considered
cells presented a shift in fluorescence intensity due to NCs
internalization at this time point.
For the tests in combination with SW, the effects of single
toward multiple SW treatments were compared.
The analyses started looking for the safest conditions for KB
cells under SW stimulation in absence of ZnO NCs. Based on
the previous literature investigations (Canaparo et al., 2006, 2013;
Serpe et al., 2011; Foglietta et al., 2017), a fixed number of shots
(500 or 1000) was adopted, varying the PPP (29.1, 39.4, 50.3,
61.7, and 74.1 MPa). The cell viability decreased at increasing
either the SW energies (from 29.1 MPa up to 74.1 MPa) or the
number of shots (either 500 or 1000 shots), as evidenced in
Figure 4. The related complete statistical analysis is reported in
the Supplementary Material.
To prove the effective synergy between the SW and the ZnO
NCs, the conditions where the cell viability were closest to
100 % with the sole stimulation (either SW alone or ZnO NC
alone) were then selected. Cells were pre-incubated for 24 h with
ZnO NCs at the concentration of 10 µg/mL and then treated
with SW (ZnO NCs + SW). 24 h after the SW irradiation, cell
viability was measured. The viabilities of untreated cells (Ctrl),
cells incubated with ZnO NCs but not treated with SW (ZnO
NCs) and cells treated only with SW in absence of ZnO NCs (SW)
were also kept for comparison. The employed SW parameters
were 29.1 MPa, 1000 shots (Figure 5A), 39.4 MPa, 500 shots
FIGURE 4 | KB cell viability upon SW treatment measured by the WST-1
proliferation assay. KB cells were treated with SW characterized by a different
PPP and number of shots, as indicated in the bars legend. Results are shown
as mean ± SEM percentage of cell viability with respect to control cells. n = 3.
(Figure 5B), 39.4 MPa, 1000 shots (Figure 5C) and 50.3 MPa,
500 shots (Figure 5D).
Interestingly, no differences in cell viability were evidenced
between SW and ZnO NCs + SW cells, indicating that there
was not a synergism between ZnO NCs and SW with the single
treatment modality.
Multiple US treatments are routinely employed alone or in
combination with drugs or nanoparticles in several in vitro,
in vivo and in clinical trials studies (Ramirez et al., 1997; Hill
et al., 2005; Wang et al., 2008; Ninomiya et al., 2012; Katiyar
et al., 2014; Huang et al., 2018). Very recently, Marino et al. (2018,
2019) obtained positive results in terms of cell death combining
barium titanate nanoparticles and multiple US treatments in an
in vitro study. In these investigations, cells were treated 1 h/day
for 4 consecutive days. This method was indeed applied here with
some modifications and using ZnO NCs and SW on KB cells. The
multiple SW dose was given by irradiating the KB cells three times
in a day (a treatment every 4 h). 24 h after the last irradiation, cell
viability was measured with the WST-1 assay as before.
As it is possible to observe in Figure 6, the cells incubated
with ZnO NCs and subjected to multiple SW treatments always
showed less viability than the control ones. In the first three
cases, regarding cells treated with SW 29.1 MPa-1000 shots,
39.4 MPa-500 shots and 1000 shots (reported in Figures 6A–C,
respectively), only those incubated with NCs and treated with
SW were appreciably less viable than the controls. However,
these results were not statistically different from the control
experiments. Strikingly, the cells incubated with ZnO NCs
and treated with SW with a PPP of 50.3 MPa and 500
shots (Figure 6D) resulted in a significant lower cell viability
(47 ± 11%) not only with respect to the control or to the
ZnO NCs cells w/o SW (100% of viability), but also with cells
treated with only SW (p < 0.01 with a viability of 93 ± 9%)
without NCs. Therefore, the anti-proliferative effect observed
with the combination of ZnO NCs and multiple SW treatments
was impressive and not found in the controls. These results
suggest the existence of a powerful synergy between ZnO NCs
and SW. While a single SW treatment is not able to induce a
significant variation in ZnO NCs + SW cells, three consecutive
SW treatments effectively result in a reduced cell viability.
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FIGURE 5 | Study on the possible synergistic effect of ZnO NCs and SW. Four different samples were prepared per assay. Control untreated cells (Ctrl), cells only
incubated with 10 µg/mL ZnO NCs for 24 h (ZnO NCs), cells treated with SW (SW) and cells incubated with NCs and treated with SW (ZnO NCs + SW). Cells were
treated with SW at: (A) 29.1 MPa, 1000 shots, (B) 39.4 MPa, 500 shots, (C) 39.4 MPa, 1000 shots, (D) 50.3 MPa, 500 shots. Cell viability was recorded 24 h after
the SW treatment with the WST-1 proliferation reagent. Data are reported as the cell viability with respect to the control referred as the 100%. Results are shown as
mean ± SEM. n = 4. *p < 0.05.
Several SDT studies employ ROS scavengers to elucidate
the ROS role in cell death upon the sonosensitizer activation
(Brazzale et al., 2016; Canavese et al., 2018). In this regard,
the experiments with ZnO NCs were repeated pre-incubating
KB cells with two different antioxidants (NAC and MAN),
using the experimental conditions where a significant difference
between SW and ZnO NCs + SW cells was detected, i.e., with
SW PPP 50.3 MPa, 500 shots, 3 treatments (Figure 7). Both
NAC and MAN resulted to be non-toxic for KB cells in the
chosen concentrations and times of incubation. Furthermore,
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FIGURE 6 | Study of the possible synergistic effect of ZnO NCs and multiple SW treatments (3 times/day). Four different samples were prepared per assay. Control
untreated cells (Ctrl), cells only incubated with 10 µg/mL ZnO NCs for 24 h (ZnO NCs), cells treated with SW (SW) and cells incubated with NCs and treated with SW
(ZnO NCs + SW). Cells were treated with SW at: (A) 29.1 MPa, 1000 shots, (B) 39.4 MPa, 500 shots, (C) 39.4 MPa, 1000 shots, (D) 50.3 MPa, 500 shots. Cell
viability was recorded 24 h after the SW treatment with the WST-1 proliferation reagent. Data are reported as the cell viability with respect to the control referred as
the 100%. Results are shown as mean ± SEM. n = 4. **p < 0.01.
the percentages of cell viability of ZnO NCs treated cells did
not change with the addition of the antioxidants. Surprisingly,
no cell viability recoveries were observed in ZnO NCs + SW
samples, with both the scavengers. Furthermore, the presence of a
scavenger seemed to already decrease the viability of SW-treated
cells (in absence of ZnO NCs). In particular, only SW-treated
cells percentage of viability shifted from 93 ± 9% (obtained
from Figure 6D) to 58 ± 14% with NAC (Figure 7A) and to
59 ± 13% when pre-treated with MAN (Figure 7B). In contrast
to the previous results, SW-treated cells resulted in a significant
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FIGURE 7 | Investigating the mechanism with ROS scavengers NAC (A) and MAN (B). Five samples were prepared per assay. Ctrl were cells without the
antioxidants; Cells+NAC and Cells+MAN were cells incubated with the antioxidants; ZnO NCs+NAC or MAN were cells incubated with 10 µg/mL ZnO NCs for 24 h
and then with the antioxidants; SW+NAC or MAN were cells incubated with the antioxidants and treated with SW; and ZnO NCs+SW+NAC or MAN were cells
incubated with NCs and the antioxidants, and then irradiated with SW PPP 50.3 MPa, 500 shots (3 treatments/day). Data are reported as the cell viability with
respect to the control referred as the 100%. Results are shown as mean ± SEM. n = 6. ***p < 0.001, **p < 0.01 and *p < 0.05.
decreased viability with respect to control cells (p < 0.01 in both
cases), to the cells with the antioxidants (p < 0.05 in both cases),
and to the cells with ZnO NCs and the antioxidants (p < 0.05 in
both cases). The same scenario was observed with the ZnO NCs
+ SW treated cells, where the percentage of cell viability shifted
from 47± 11% (obtained from Figure 6D) down to 28± 7% with
NAC (Figure 7A) and to 20 ± 6% with MAN (Figure 7B). Also
in this case, significant differences were evidenced between these
samples and the control cells, the cells with the antioxidants, and
the cells with ZnO NCs and the antioxidants (p< 0.001 for all the
comparisons and for both the antioxidants). Antioxidants pre-
treatment seemed indeed to enhance SW cytotoxic power instead
of allowing the recovery from SDT effects.
Actually, the ROS pivotal role on SDT is a debated question.
From the one hand, many authors showed that the addition
of an antioxidant molecule was able to protect cells from the
SDT effects, thus claiming that ROS are strongly involved in
the SDT mechanism of action (Li et al., 2012; Brazzale et al.,
2016; Huang et al., 2018). On the contrary, other researchers
proposed the mechanical stress as the main responsible of the
observed cytotoxic effects (Canavese et al., 2018). Owing to
these results, it seems here that ROS were not truly involved
in the therapeutic effect recorded with SW. On the contrary,
ROS showed to slight sustain cells proliferation, indeed their
reduction with the addition of the two antioxidants resulted
in a marked decrease of cell viability in both SW and ZnO
NCs + SW samples. This could be explained remembering that
ROS do not play always an anti-proliferative role. Instead, it is
known and reported in the literature (Mittler, 2017) that ROS
are essential for many cell functions, such as cell proliferation,
innate immune responses and differentiation. Additionally, it is
reported that ROS balance is strictly important to maintain cell
homeostasis, because also faint imbalances could result in toxic
consequences, thus their level is kept under control (Singh et al.,
2018; Asadi-Samani et al., 2019).
In this context, it is probable that the imbalance of ROS levels
caused by NAC and MAN addition followed by multiple SW
treatments resulted to be more cytotoxic, suggesting that a certain
level of ROS was perhaps necessary for KB cells to recover from
SW induced damages.
In addition, the obtained results discourage the hypothesis
of a ZnO NCs sonoluminescent activation. The production of
light flash upon inertial acoustic cavitation is actually a debated
issue. Some authors proposed the possibility of the organic
sonosensitizer activation through sonoluminescence (Ninomiya
et al., 2014; Brazzale et al., 2016; Beguin et al., 2019). In this
case, an eventual light excitation of ZnO NCs has, as a result, the
ROS overproduction with consequent cell death (Ancona et al.,
2018). However, this phenomenon was not observed with the
acoustic activation in our experiments, because a reduction in
ROS burst was here associated with less cell viability and not with
a recovery, as expected if the mechanism would be based on the
light activation.
Here, the observed synergism possibly lies on a mechanical
injury of the enhanced bubble cavitation. Indeed, the damage
could derive from bubble oscillations under non-inertial
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cavitation, or bubble implosion upon inertial cavitation (Izadifar
et al., 2017). In this view, it is reasonable to suppose that the
presence of ZnO NCs in cells subsequently irradiated with SW
decreased the cavitation threshold improving the number of
oscillating/imploding microbubbles, increasing the mechanical
stress (Canavese et al., 2018). This effect was also previously
reported by our research group using amino-functionalized ZnO
NC in the presence of continuous ultrasound irradiation in water
media (Vighetto et al., 2019).
In addition, the physical motion of nanoparticles internalized
into cells upon US irradiation could also contribute to the
cell death, even in absence of inertial cavitation, increasing
locally the temperature and leading to mechanical destruction
of the cells. This phenomenon is called “nanoscalpel effect,”
where nanoparticles physically alter organelles and nuclei
(Osminkina et al., 2015).
A further possible mechanism, in concomitance to the
above-mentioned ones, can be hypothesized based on the
ZnO piezoelectric properties. Actually ZnO, due to its non-
centrosymmetric crystal structure (Cauda et al., 2014; Racca et al.,
2018) under a mechanical stimulation, is able to generate polar
charges (Cauda et al., 2015; Laurenti et al., 2015, 2016). In this
regard, the multiple and repetitive mechanical stimulation of
ZnO NCs with the SW could also exert an electric stimulation
in the cancer cells, resulting in a decrease of cell viability. This
mechanism was also previously reported by Marino et al. with
other piezoelectric nanomaterials (Marino et al., 2018, 2019).
To better elucidate the cell killing mechanism, the real-
time measurement of both apoptotic and necrotic cells through
luminescent and fluorescent signals was performed. In details,
the used kit contains two annexin V fusion proteins associated
with two complementary subunits of the luciferase enzyme.
When the two subunits are in contact, during early apoptosis
or secondary necrosis, the luciferase reacts with a substrate
generating a luminescent signal. At the same time, a fluorescent
intercalating DNA probe lets to precisely identify secondary
necrosis. Thus, a sample negative for both signals indicates
that cells are nor in apoptosis neither in necrosis. A sample
positive for luminescence signal and not for fluorescence
one indicates an early apoptosis, while a sample positive for
both luminescence and fluorescence indicates the presence of
secondary necrosis.
The recorded results of both luminescent and fluorescent
signals are shown in Figures 8A,B, respectively. Before the
addition of the reaction mix (pre mix) and immediately before
the first SW treatment (post mix), the cell basal signal in
both luminescence and fluorescence channels was very low.
After the first SW irradiation, the SW and the ZnO NCs
+ SW treated cells immediately showed a marked increment
of luminescence, while the recorded fluorescence reported a
slight increase. After the second treatment, the SW and ZnO
NCs + SW luminescence continued to increase, as well as
the fluorescence of both samples. In contrast, after the third
treatment, the recorded luminescence was more or less the same
of the previous time point, while the fluorescence displayed a
huge increase. In particular, the signal associated to the ZnO
NCs + SW treated cells was more pronounced than the one
FIGURE 8 | Kinetic of cell death in the ZnO NCs + SW experiment.
(A) luminescence, expressed as relative light units (RLU), and
(B) fluorescence, expressed as relative fluorescence units (RFU),
measurements. KB cells were considered alone (Ctrl), incubated with
10 µg/mL ZnO NCs for 24 h (ZnO NCs), treated with SW alone every 4 h for a
total of 3 treatments in a day (SW), or incubated with ZnO NCs and then
treated for three times (a treatment every 4 h) with SW (ZnO NCs + SW).
Phosphatidylserine exposure (luminescence) and loss of the membrane
integrity (fluorescence) were measured before the addition of the reaction mix
(pre mix), after the addition but before SW treatment (post mix), after the first
(post SW I), second (post SW II) and third (post SW III) SW treatment and 24 h
after the last SW irradiation (post 24 h). n = 2.
related to only SW-treated cells (Figure 8B). After 24 h from
the treatment, the luminescent signal dropped down and the
four samples resulted to possess the same level of luminescence.
The fluorescent signals also decreased, but to a less extend in
comparison to the luminescent ones. In particular, the ZnO NCs
+ SW treated sample continued to possess a higher fluorescence
signal than the one obtained from the cells treated with only
SW. ZnO NCs-treated cells signal on the contrary showed the
same trend of the control ones, indicating that ZnO NCs at the
employed concentration and time of incubation did not induce
any apoptosis nor necrosis.
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Together, these results suggest that multiple treatments
are required indeed to exert tumor cell death. The pro-
apoptotic and necrotic effects of both SW and ZnO NCs
+ SW treated samples increased progressively after each
treatment, achieving a peak in fluorescence after the third
irradiation. Additionally, the fluorescent signals associated to
ZnO NCs + SW treated cells showed a difference from the
SW treated sample after the third treatment. This evidence
agrees with the previous experiments, where no differences
between SW and ZnO NCs + SW samples after a single SW
treatment was evidenced. Here it was demonstrated that at least
three treatments are required in order to obtain the desired
synergistic effect.
Moreover, analyzing the trend of the two signals in Figure 8,
the presence of an early apoptosis is highlighted after the first
treatment, becoming, as expected, secondary necrosis in the
next steps. The progressive increase of luminescence followed
by an increase of the fluorescence signal is indeed typical of
an apoptotic phenotype (Hassan et al., 2018). In this case,
it is suggested that an apoptotic pathway is induced in both
SW and ZnO + SW treated samples. However, the synergistic
combination of the two stimuli resulted in a more pronounced
cell death, as it was evidenced with the WST-1 tests of
Figure 6D. The complete statistical analysis is reported in the
Supplementary Material.
SW multiple treatments alone on KB cells were apparently able
to first induce apoptosis and later, secondary necrosis. However,
WST-1 results (Figure 6D) indicate that cancer cells recovered
after 24 h from the last treatment, and thus the induced damages
were reverted. This result is in accordance to what reported by
Canaparo et al., who already observed that SW treatment was able
to improve the percentage of cells in both apoptosis and necrosis
(Canaparo et al., 2013).
Strikingly, the cells treated with ZnO NCs + SW were not able
to recover, confirming that the synergistic action of ZnO NCs
and SW induced irreversible consequences, resulting in a loss
of cell viability.
The association between apoptosis and US is largely reported
in the literature, even if the mechanism driving this event is not
fully understood. US are indeed able to induce this type of cell
death activating various pathways (Wan et al., 2016; Canavese
et al., 2018; Huang et al., 2018).
Previous studies with SW associated with a photosensitizer,
even if in a single dose, recorded a remarkable apoptosis and
secondary necrosis caused by this synergy (Canaparo et al., 2006,
2013; Serpe et al., 2011). However, these estimations occurred at
a single time point, while here we evaluated the trend over time
at multiple SW stimulations.
Based on these results and the state of the art, it is thus
hypothesized here that the apoptosis is caused by cell mechanical
injury upon ZnO NCs and SW co-administration. Actually, it
was previously observed that mechanical stress could result in
DNA damage, with the activation of the apoptotic pathway
(Furusawa and Kondo, 2017). Moreover, it was reported that
SW mechanotransduction could exert an apoptotic pathway
(d’Agostino et al., 2015), and the previously cited “nanoscalpel
effect” is also related to apoptosis (Osminkina et al., 2015).
CONCLUSION
Herein the effects of amino-propyl functionalized ZnO NCs in
combination with SW to treat cancer cells were investigated.
Amino-propyl functionalized ZnO NCs were synthetized and
characterized, confirming their single crystalline structure,
with a spherical morphology and positive Z-potential, as
previously reported (Garino et al., 2019a). Cytotoxicity
tests let to identify the maximum non-lethal dose of the
sole NCs. With internalization assays instead, the optimal
incubation time to achieve a good internalization of ZnO NCs
was undertaken.
After a preliminary phase dedicated to the study of the
sole SW cytotoxicity, experiments involving both ZnO NCs
and SW were carried out. It was discovered that a single
treatment was not sufficient to achieve a significant difference
in cells viability between SW and ZnO + SW stimulations. In
contrast, multiple SW treatments (3 times/day) resulted to be
highly cytotoxic and, strikingly, only for cells pre-incubated with
ZnO NCs. Studies on the mechanism were then performed,
finding that ROS role was controversial and seemed to be
protective instead of being toxic. By exploring the kinetics of
cell death, it was demonstrated that SW administration resulted
in a pro-apoptotic stimulus. However, the ZnO NCs + SW
stimuli led to high cell suffering, with an enhanced fluorescent
signal associated with secondary necrosis and confirming
what observed with the WST-1 viability assay. Additionally,
it was highlighted that, only after the third treatment, an
increase of ZnO NCs + SW fluorescent signals occurred with
respect to the sole SW ones, suggesting the importance of
the synergistic combination between ZnO NCs administration
and SW stimulus.
Even if the elucidation of the exact mechanism of cell death
is the focus of our current studies, we proposed here the
combination of various effects, including the mechanical injury
due to (i) the enhanced bubble cavitation and (ii) the so-
called “nanoscalpel effect,” as well as (iii) an electric change
imbalance, potentially involving the piezoelectric behavior
of ZnO.
Despite the previous report concerning the use of SW in
presence or not with organic sonosensitizing molecules, this is
the first time where a solid and dense nanomaterial, i.e., ZnO,
results to be toxic in combination with SW. These results open
the possibility of a future application of ZnO NCs and SW as an
effective nanomedicine tool for cancer therapy.
FUTURE OVERVIEW
Further investigations about the mechanism of the observed
synergy and cell death are required. In particular, dedicated
quantitative and qualitative analysis could be performed to
explain the synergy, such as gene expression to better understand
the molecular mechanism (Foglietta et al., 2015), the evaluation
of morphological modifications with a direct observation
through fluorescence microscopy and transmission electron
microscopy (Dai et al., 2014; Defour et al., 2014) and several
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other tests to observe typical SW and ZnO nanoparticles related
damages (Izadifar et al., 2017; Garino et al., 2019b). Moreover,
the electric stimulation consequences could be measured, as
suggested by other authors (Marino et al., 2018, 2019). Direct
evaluation of intracellular ROS production, mechanical and
electrical injuries are also further tests to be done for a better
comprehension of the phenomenon. A different distribution of
treatments and number of shots could also be tested in order
to maximize the synergy. Since the ZnO specific toxicity toward
cancer cells is reported in the literature (Racca et al., 2018;
Dumontel et al., 2019), additional tests with ZnO NCs and SW
on healthy cells could be performed to confirm the selectivity
of the proposed anticancer approach before to proceed with
in vivo investigations.
An additional enhancement could be generated by improving
the colloidal dispersibility of ZnO NCs (Dumontel et al., 2019;
Limongi et al., 2019). These interesting features could be
successfully exploited for a future application of ZnO NCs and
SW in in vivo investigations and clinic. An enhanced biostability
can thus decrease the aggregation in biological fluids, improve the
in vivo biodistribution and allow for future selective targeting to
cancer cells, by anchoring targeting ligands.
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